Back to top
more

Globus Medical (GMED)

(Delayed Data from NYSE)

$73.43 USD

73.43
684,127

+0.80 (1.10%)

Updated Jul 22, 2024 04:00 PM ET

After-Market: $73.40 -0.03 (-0.04%) 4:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (143 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for GMED

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Globus Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 518 446 443 427 311
Receivables 505 217 166 148 162
Notes Receivable 0 0 0 0 0
Inventories 848 299 237 229 196
Other Current Assets 45 21 18 18 17
Total Current Assets 1,915 983 865 822 687
Net Property & Equipment 587 244 221 217 200
Investments & Advances 75 496 562 359 410
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 11 49 24 7 6
Intangibles 2,359 261 248 244 208
Deposits & Other Assets 79 43 36 32 22
Total Assets 5,086 2,076 1,957 1,679 1,532
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 57 36 22 18 25
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 240 95 91 78 63
Income Taxes Payable 4 1 1 1 1
Other Current Liabilities 79 27 26 23 22
Total Current Liabilities 392 159 140 121 111
Mortgages 0 0 0 0 0
Deferred Taxes/Income 84 2 4 6 6
Convertible Debt 0 0 0 0 0
Long-Term Debt 417 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 103 69 71 46 12
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,088 230 216 173 130
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,871 631 554 457 357
Retained Earnings 1,137 1,240 1,194 1,045 1,048
Other Equity -10 -25 -7 4 -3
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 3,998 1,846 1,741 1,506 1,402
Total Liabilities & Shareholder's Equity 5,086 2,076 1,957 1,679 1,532
Total Common Equity 3,998 1,846 1,741 1,506 1,402
Shares Outstanding 136.30 100.10 101.50 99.70 99.80
Book Value Per Share 29.33 18.45 17.16 15.11 14.05

Fiscal Year End for Globus Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 434 518 469 613
Receivables NA 535 505 496 242
Notes Receivable NA 0 0 0 0
Inventories NA 816 848 905 336
Other Current Assets NA 43 45 48 20
Total Current Assets NA 1,829 1,915 1,917 1,210
Net Property & Equipment NA 579 587 607 248
Investments & Advances NA 51 75 276 392
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 11 11 7 62
Intangibles NA 2,339 2,359 2,384 254
Deposits & Other Assets NA 78 79 69 47
Total Assets NA 4,944 5,086 5,356 2,212
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 50 57 87 34
Current Portion Long-Term Debt NA 424 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 210 240 222 90
Income Taxes Payable NA 43 4 34 2
Other Current Liabilities NA 47 79 72 30
Total Current Liabilities NA 786 392 429 155
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 40 84 132 5
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 417 410 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 103 98 67
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,021 1,088 1,169 227
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 2,886 2,871 2,858 657
Retained Earnings NA 1,047 1,137 1,348 1,347
Other Equity NA -11 -10 -19 -19
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 3,922 3,998 4,187 1,985
Total Liabilities & Shareholder's Equity NA 4,944 5,086 5,356 2,212
Total Common Equity 0 3,922 3,998 4,187 1,985
Shares Outstanding 135.30 135.30 136.30 140.60 100.40
Book Value Per Share 0.00 28.99 29.33 29.78 19.77